Technical Indicator Analysis for Alder Biopharmaceuticals Inc. (NASDAQ:ALDR)

85

Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) for the period of 9-Day stands at 24.79% while the stochastic %D for the same period stands at 32.74%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Buy”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) while 20-100 Day MACD Oscillator indicates “Sell”.

Bollinger band is a volatility indicator of a certain security, currently Alder Biopharmaceuticals Inc. (NASDAQ:ALDR)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Alder Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and seeks to commercialize therapeutic antibodies. It is developing monoclonal antibodies comprising ALD403, for the prevention of migraine; and Clazakizumab, in the treatment of rheumatoid arthritis and psoriatic arthritis. Alder Biopharmaceuticals Inc. is headquartered in Bothell, Washington.

Previous Day Activity Analysis

On the last trading day, Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) opened the session at $12.25 and after going down -1.63% closed at $12.1. The stock lost -0.15 points in the last trade.

Alder Biopharmaceuticals Inc. (NASDAQ:ALDR)’s stock fluctuated in the range of $11.85 and $12.40 during the previous active session. Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) traded with the volume of 743597 with average volume of 1.34 Million. The stock has LOW volatility on the last trading session.

Currently the Beta for the company remains at 2.62 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.57 and 60.34 respectively.

Currently the Insider Ownership of the shares of Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) is at 1.35% and the shares outstanding are 67.17 Million.

Important Ratio Analysis

Some important ratios to consider here for Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) are discussed below:

Dividend yield of Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The Price to Sale P/S and Price to Book P/B shows the value of 1161.08 and 2.78 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 3.62 and 0 correspondingly.

The Quick Ratio of Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) stands at 7.2 while the Current Ratio depicts the value of 7.2.

Return on Assets ROA of Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) is at -72.7% whereas, Return on Equity ROE and Return of Investment ROI of Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) stand at -78.7% and -41.2% respectively.

Stock Performance Analysis

The stock performance of Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) on the basis of 5 day trade show the dip of -1.22% whereas, the monthly performance of the stock shows increase of 15.24%.

The quarterly performance of the stock remained in green zone with the value of 0.83% while six month performance of the shares of Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) remained bearish with the count of -40.83%.

The yearly and YTD performance of Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) remained down at -56.24% and -41.83% respectively.